VITR Vitrolife AB (publ)
92.70SEK+3.40%Mkt Cap: 1.20B $P/E: —Today
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse…
Industry Peers
Medical Devices$170.98BUSDP/E 31.7
$111.40BUSDP/E 21.4
$106.71BUSDP/E 28.8
$61.14BUSDP/E 17.1
$49.80BUSDP/E 51.5
$46.31BUSDP/E 19.3
$31.47BUSDP/E 33.1
$29.46BUSDP/E 14.9
$22.91BUSDP/E 18.7
$23.60BUSDP/E 18.0
$20.34BUSDP/E 25.5
$17.13BUSDP/E 28.0
$17.11BUSDP/E 21.8
$12.49BUSDP/E 77.9
$11.25BUSDP/E 18.3
$10.51BUSD
$10.26BUSDP/E 19.6
$9.97BUSDP/E 28.3
$9.87BUSDP/E 46.7
$9.53BUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
Vitrolife AB (VTRLY) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Challenges Vitrolife AB (VTRLY) reports strong growth in the Americas and successful product launches, but faces regional challenges impacting overall performance. | ||